Please assess the completion status of the following clinical trial:

Trial Title: The Synergistic Effect of Dexmedetomidine on Propofol for Sedation for Pediatric Endoscopy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ages 7-18 years who are scheduled for upper or lower endoscopic procedures at Boston Children's Hospital and meets criteria to receive dexmedetomidine or propofol sedation for upper and lower endoscopic procedures~* Provides written consent to participate in the research study~* For females of childbearing age, pregnancy test is negative~Exclusion Criteria:~* Do not meet established sedation criteria~* Refuses administration of study medication prior to sedation~* History of allergy, intolerance, or reaction to dexmedetomidine or propofol or hypersensitivity~* Current, repaired or risk of Moya-Moya disease~* Recent stroke (cerebrovascular accident) within past 6 months~* Uncontrolled hypertension~* Concomitant use of opioids, beta antagonist, alpha 2 agonist or calcium channel blocker~* Egg, soy or lecithin allergy~* BMI greater than 30 or weight above 110th percentile~* Refuses insertion of intravenous catheter while awake~* Currently receiving pharmacologic agents for hypertension or cardiac disease~* Currently receiving or has received digoxin within the past 3 months~* Active, uncontrolled gastroesophageal reflux - an aspiration risk~* Current (or within past 3 months) history of apnea requiring an apnea monitor~* Unstable cardiac status (life threatening arrhythmias, abnormal cardiac anatomy, significant cardiac dysfunction)~* Craniofacial anomaly, which could make it difficult to effectively establish a mask airway for positive pressure ventilation if needed~* Active, current respiratory issues that are different from the baseline status (pneumonia, exacerbation of asthma, bronchiolitis, respiratory syncytial virus)

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Propofol (Group P) (Type: ACTIVE_COMPARATOR): Propofol only
- Propofol with Dexmedetomidine (Group DP) (Type: ACTIVE_COMPARATOR): Propofol with Dexmedetomidine

Based on this trial design, predict the completion outcome and termination type (if applicable).